OP2LYSIS DEVELOPMENT
Voor OP2LYSIS DEVELOPMENT is een faillissementsprocedure geopend volgens publicaties in het Belgisch Staatsblad. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 5 jaar |
| Vestigingen | 1 |
| Publicaties | 4 |
Faillissement geopend
Er loopt al een faillissementsprocedure — een kans-score is dan niet meer zinvol. Bekijk de insolventietijdlijn voor de stand van de procedure.
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 18-06-2025 | 2025-00155741 |
| 31-12-2023 | volledig | 13-06-2024 | 2024-00142676 |
| 31-12-2022 | volledig | 28-07-2023 | 2023-00308319 |
| Rol | Naam | Periode | Bron |
|---|---|---|---|
| Curator | LAURENT STAS DE RICHELLE RUE CONSTANTIN
DE GERLACHE 41, 4000 LIEGE 1 |
27-10-2025 → heden | Belgisch Staatsblad |
| Curator | CATHERINE
DELBOUILLE AVENUE CONSTANTIN DE GERLACHE 41,
4000 LIEGE 1 |
27-10-2025 → heden | Belgisch Staatsblad |
| NACE primair | 72101 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 17-06-2021 |
| Status | Actief |
| Postcode | 4000 |
| Eerste BS-signaal | 13-11-2025 |
| Laatste BS-signaal | 13-11-2025 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 62042B0366/00B003 | Wallonië | 1,9 ha | — | — |
| 62064A0220/00G000 | Wallonië | 8.511 m² | 1 · 1.406 m² | 12,8 m · 3 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
17-01-2024 Kapitaalverhoging van €400.000 tot €1.461.490
- €1.061.490 → €1.461.490
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1461490.0,
"delta_eur": 400000.0,
"before_eur": 1061490.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "OP2LYSIS",
"share_class": null,
"liberation_pct": 25.0,
"contribution_kind": "numeraire",
"n_shares_subscribed": 650,
"contribution_amount_eur": 400000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 650,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 615.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 100000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": 300000.0,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "G\u00E9rard INDEKEU",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-01-17",
"filing_date": "2024-01-15",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-12-06",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0769.816.843",
"name_full": "OP2LYSIS DEVELOPMENT",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procuration",
"statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": "0769.816.843",
"pct": 100.0,
"kind": "org",
"name": "OP2LYSIS DEVELOPMENT",
"role": "aandeelhouder",
"n_shares": 2376,
"share_class": null
}
],
"share_classes_after": []
}29-11-2022 Kapitaalverhoging van €999.990 tot €1.061.490
- €61.500 → €1.061.490
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1061490.0,
"delta_eur": 999990.0,
"before_eur": 61500.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "GAUDIN Christophe",
"share_class": null,
"liberation_pct": 25.0,
"contribution_kind": "numeraire",
"n_shares_subscribed": 1626,
"contribution_amount_eur": 999990.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1626,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 615.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 249997.5,
"n_shares_destroyed": null,
"not_yet_called_eur": 749992.5,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "G\u00E9rard INDEKEU",
"firm_city": null,
"firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-11-29",
"filing_date": "2022-11-25",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-11-15",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2022-11-15"
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": "none",
"individual_name": null
},
"subject_company": {
"kbo": "0769.816.843",
"name_full": "OP2LYSIS DEVELOPMENT",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procurations",
"statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "GAUDIN Christophe",
"role": null,
"n_shares": 1626,
"share_class": null
}
],
"share_classes_after": []
}29-11-2022 Zetelverplaatsing binnen Liège
- 4000 Liège, Avenue du Parc Industriel, 89 → 4000 Liège, Boulevard Patience et Beaujonc, 3, Legia Park
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "4000 Li\u00E8ge, Boulevard Patience et Beaujonc, 3, Legia Park",
"city": "Li\u00E8ge",
"region": "waals_gewest",
"street": "Boulevard Patience et Beaujonc",
"country": "BE",
"postcode": "4000",
"box_number": null,
"street_number": "3",
"locality_suffix": null
},
"old_address": {
"raw": "4000 Li\u00E8ge, Avenue du Parc Industriel, 89",
"city": "Li\u00E8ge",
"region": "waals_gewest",
"street": "Avenue du Parc Industriel",
"country": "BE",
"postcode": "4000",
"box_number": null,
"street_number": "89",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "G\u00E9rard INDEKEU",
"firm_city": null,
"firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-11-29",
"filing_date": "2022-11-25",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"date": "2022-11-15",
"unanimous": true
},
"subject_company": {
"kbo": "0769.816.843",
"name_full": "OP2LYSIS DEVELOPMENT",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": "CG HEALTH VALUE",
"person_name": "Christophe GAUDIN",
"org_rep_person_name": null,
"person_role_at_subject": "Pr\u00E9sident"
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procurations",
"statuts coordonn\u00E9s"
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | OP2LYSIS DEVELOPMENT |